Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|November 26, 2015
Nuclear Factor of Activated T Cells-dependent Down-regulation of the Transcription Factor Glioma-associated Protein 1 (GLI1) Underlies the Growth Inhibitory Properties of Arachidonic AcidAndrea Comba, Luciana L Almada, Ezequiel J Tolosa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2025
Nuclear Galectin-1 promotes <i>KRAS</i>-dependent activation of pancreatic cancer stellate cellsJudith Vinaixa, Neus Martínez-Bosch, Joan Gibert, et al.
The Journal of Biological Chemistry|April 6, 2021
A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibitionIsaac P Horn, David L Marks, Amanda N Koenig, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 12, 2020
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combinationRyan M Carr, Narjust Duma, Angela L McCleary-Wheeler, et al.
Epigenetics|July 31, 2018
Epigenetics of gastrointestinal diseases: notes from a workshopDavid L Marks, Rachel L Olson, Raul Urrutia, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
The Biochemical Journal|August 9, 2020
GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expressionEzequiel J Tolosa, Maite G Fernandez-Barrena, Eriko Iguchi, et al.
Nature Communications|May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axisRyan M Carr, Denis Vorobyev, Terra Lasho, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 3, 2019
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancerAngela L McCleary-Wheeler, Ryan M Carr, Shanique R Palmer, et al.
Cancer Research Communications|June 19, 2024
KRAS Promotes GLI2-Dependent Transcription during Pancreatic CarcinogenesisAshley N Sigafoos, Ezequiel J Tolosa, Ryan M Carr, et al.
Pageof 6